Long-term supplementation of honokiol and magnolol ameliorates body fat accumulation, insulin resistance, and adipose inflammation in high-fat fed mice. 2013

Young-Je Kim, and Myung-Sook Choi, and Byung Yoon Cha, and Je Tae Woo, and Yong Bok Park, and Sang Ryong Kim, and Un Ju Jung
Department of Food Science and Nutrition, Kyungpook National University, Daegu, Republic of Korea.

METHODS This study investigated the effect of honokiol (HON) and magnolol (MAG), phenolic compounds in Magnolia plants, on adiposity and adiposity-related metabolic disturbances in mice fed high-fat diet (HFD), and the potential underlying mechanisms focusing on the lipid metabolism and inflammatory response. RESULTS C57BL/6J mice were fed HFD (45 kcal% fat) with or without HON (0.02%, w/w) or MAG (0.02%, w/w) for 16 wk. Despite no changes in body weight, food intake, and hepatic fat accumulation, HON and MAG significantly lowered the weight of white adipose tissue (WAT) as well as adipocyte size and protected against insulin resistance induced by HFD. These effects were associated with increases in energy expenditure and adipose fatty acid oxidation and decreases in fatty acid synthase activity and expression of genes related to fatty acid synthesis, desaturation, and uptake, as well as adipocyte differentiation in WAT. Moreover, HON and MAG significantly lowered the expression of proinflammatory genes in WAT and elevated the plasma IL-10 level. Particularly, HON significantly decreased the plasma resistin level and increased the plasma adiponectin level compared to the control group. CONCLUSIONS HON and MAG have potential as novel agents for amelioration of adiposity and associated insulin resistance and inflammation.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D004734 Energy Metabolism The chemical reactions involved in the production and utilization of various forms of energy in cells. Bioenergetics,Energy Expenditure,Bioenergetic,Energy Expenditures,Energy Metabolisms,Expenditure, Energy,Expenditures, Energy,Metabolism, Energy,Metabolisms, Energy
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral

Related Publications

Young-Je Kim, and Myung-Sook Choi, and Byung Yoon Cha, and Je Tae Woo, and Yong Bok Park, and Sang Ryong Kim, and Un Ju Jung
February 2021, Acta pharmacologica Sinica,
Young-Je Kim, and Myung-Sook Choi, and Byung Yoon Cha, and Je Tae Woo, and Yong Bok Park, and Sang Ryong Kim, and Un Ju Jung
February 2016, Phytomedicine : international journal of phytotherapy and phytopharmacology,
Young-Je Kim, and Myung-Sook Choi, and Byung Yoon Cha, and Je Tae Woo, and Yong Bok Park, and Sang Ryong Kim, and Un Ju Jung
November 2023, Amino acids,
Young-Je Kim, and Myung-Sook Choi, and Byung Yoon Cha, and Je Tae Woo, and Yong Bok Park, and Sang Ryong Kim, and Un Ju Jung
July 2019, European journal of pharmacology,
Young-Je Kim, and Myung-Sook Choi, and Byung Yoon Cha, and Je Tae Woo, and Yong Bok Park, and Sang Ryong Kim, and Un Ju Jung
January 2019, BioMed research international,
Young-Je Kim, and Myung-Sook Choi, and Byung Yoon Cha, and Je Tae Woo, and Yong Bok Park, and Sang Ryong Kim, and Un Ju Jung
May 2022, Biomolecules,
Young-Je Kim, and Myung-Sook Choi, and Byung Yoon Cha, and Je Tae Woo, and Yong Bok Park, and Sang Ryong Kim, and Un Ju Jung
February 2020, Life sciences,
Young-Je Kim, and Myung-Sook Choi, and Byung Yoon Cha, and Je Tae Woo, and Yong Bok Park, and Sang Ryong Kim, and Un Ju Jung
December 2021, Adipocyte,
Young-Je Kim, and Myung-Sook Choi, and Byung Yoon Cha, and Je Tae Woo, and Yong Bok Park, and Sang Ryong Kim, and Un Ju Jung
December 2012, Diabetes,
Young-Je Kim, and Myung-Sook Choi, and Byung Yoon Cha, and Je Tae Woo, and Yong Bok Park, and Sang Ryong Kim, and Un Ju Jung
June 2013, Diabetes,
Copied contents to your clipboard!